Replies to post #19415 on Arrayit Corporation (ARYC)

[MikeCr]

Johnny - You are probably right.

Also, the AVDX float is now probably less than 10M shares. As of August 10, 2015, there were 94,434,743 shares of AVDX common stock outstanding. Of those most are owned by Arrayit and other individuals. So for liquidity purposes, if good AVDX news comes out, it may be to Avant's benefit to have a 20M shares float.

[General_Sevier]

They haven't secured any "loan"...... they are cashless and desperate........

This 10,000,000 share dividend was actually required under the settlement agreement and all parties have apparently been horrified at it having to be distributed.........

AVDX hasn't even filed the needed S-1 to register the shares so anybody could sell them if they wanted to...


A mere 100,000 of the 10,000,000 being sold will likely send AVDX stock down to under 5 cents....

And from public information, testing hasn't started (after 5 years of not doing it) because there is no qualified place that has been engaged to do it (under blind protocols and under the supervision of an FDA approved investigator). This was suppose to be done in an ARYC CLIA certified lab but that doesn't exist....

And even then, that is just to see if it works to even go to the FDA with a pre-IDE seeking approval and protocols to do a stringent and costly "trial" to proof efficacy in a necessary way..